July 6, 2015 by Geoff Walden and Chain Drug Review
Adam Fein, Brian Cornell, CVS Health, CVS/pharmacy, Drug Channels Institute, Larry Merlo, MinuteClinic, Pembroke Consulting, Target Corp., TargetExpress
2015, Issue 07-06-2015, Issues, News

WOONSOCKET, R.I. — Continuing its aggressive growth and diversification, CVS Health has purchased Target Corp.’s pharmacy and clinic businesses for some $1.9 billion. The acquisition propels CVS past Walgreens as the nation’s No. 1 pharmacy operator by market share and store count. CVS will have close to 9,500 prescription counters. Walgreens had 8,232 as of
July 6, 2015 by Geoff Walden and Chain Drug Review
Alex Perez-Tenessa, Cia Tucci, CVS Health, CVS/pharmacy, CVS/pharmacy y más, ExtraCare, health and beauty, Helena Foulkes, Judy Sansone, new front end, new store designs
2015, Issue 07-06-2015, Issues, News

NEW YORK — CVS Health has unveiled an enhanced front end with a focus on health, beauty and consumables. The upgrade, being rolled out at selected stores starting with 150 high-volume urban outlets, is “the next step in the company’s evolution to better support customers’ health in its retail stores” following its cigarette ban, CVS
July 6, 2015 by Mark Baumgartner and Chain Drug Review
Affordable Care Act, health insurance, health insurance exchanges, King v. Burwell, National Association of Chain Drug Stores, National Community Pharmacists Association, National Retail Federation, Supreme Court
Issue 07-06-2015, Issues, News
WASHINGTON — The Affordable Care Act has survived its second Supreme Court challenge, with a divided court agreeing with the Obama administration that government subsidies that make health insurance affordable for millions of poor and middle-class Americans should be available nationwide. While there are more challenges to come, the organization representing the nation’s traditional drug
July 6, 2015 by Scot Meyer and Chain Drug Review
fees charged to suppliers, supplier agreements, Walmart
2015, Business, Issue 07-06-2015, Issues, News, Retail News

BENTONVILLE, Ark. — Walmart will begin charging most of its suppliers new fees for stocking their products in new stores and for storing them in its warehouses. About 91% of Walmart’s suppliers will be affected, according to a company spokeswoman, who notes that some product categories, including adult beverages and produce, will be exempt. The
July 6, 2015 by Scot Meyer and Chain Drug Review
Brian Cornell, chief merchandising and supply chain officer, Kathee Tesija, Target Corp.
2015, Issue 07-06-2015, Issues, News
MINNEAPOLIS — Kathee Tesija is leaving her post as executive vice president and chief merchandising and supply chain officer at Target Corp., moving into an advisory role with the retailer. The company is conducting an external and internal search for Tesija’s replacement, according to Target chairman and chief executive officer Brian Cornell, who said “this
July 6, 2015 by John Schultz and Chain Drug Review
Adam Pellegrini, Balance Rewards for healthy choices, diabetes, digital health, Harry Leider, hypertension, medication adherence, Walgreens
Issue 07-06-2015, Issues, News
DEERFIELD, Ill. — Walgreen Co. says that its Balance Rewards for healthy choices (BRhc) program, which awards loyalty points for healthy behaviors and activities, is helping members lose weight and driving better medication adherence among participants with hypertension and/or diabetes. According to a new white paper and outcomes data the company released, active members who
July 6, 2015 by Mark Baumgartner and Chain Drug Review
Envision Pharmaceutical Services, EnvisionRx, Frank Sheehy, John Standley, PBM, Rite Aid
2015, Issue 07-06-2015, Issues, News
CAMP HILL, Pa. — Rite Aid has completed its acquisition of Envision Pharmaceutical Services from private investment firm TPG and other shareholders in a transaction valued at about $2 billion, including about $1.8 billion in cash, and around 27.9 million Rite Aid shares. EnvisionRx will operate as a wholly owned subsidiary of Rite Aid under
July 6, 2015 by Chain Drug Review
Brian Tilzer, connected health, CVS Health, Digital Innovation Lab
2015, Issue 07-06-2015, Issues, News
BOSTON — CVS Health has officially opened its Digital Innovation Lab, a facility focused on developing cutting-edge services and personalized capabilities for an accessible and integrated pharmacy and health experience. The lab will be a hub for the company’s rapidly growing digital team. “The work we are doing here is not only cool — and
July 6, 2015 by John Schultz and Chain Drug Review
Burman's Specialty Pharmacy, Diplomat Pharmacy, Phil Hagerman, specialty pharmacy, Steve Burman
2015, Issue 07-06-2015, Issues, News
FLINT, Mich. — Diplomat Pharmacy Inc. has acquired Burman’s Specialty Pharmacy in an $82.8 million deal. Burman’s, based in Pennsylvania, is a provider of individualized patient care with a primary focus on hepatitis C. “Burman’s shares our strong commitment to patient care,” said Diplomat chairman and chief executive officer Phil Hagerman. “We acquired Burman’s to
July 6, 2015 by Mark Baumgartner and Chain Drug Review
chief marketing officer, CVS Health, CVS/pharmacy, DigitasLBi, Helena Foulkes
2015, Issue 07-06-2015, Issues, News
WOONSOCKET, R.I. — CVS Health has hired Norman de Greve as its chief marketing officer, effective July 15. De Greve joins CVS from DigitasLBi, where for the past year he served as head of the company’s Boston-Detroit region. DigitasLBi bills itself as “a global marketing and technology agency that transforms businesses for the digital age.”
July 6, 2015 by John Schultz and Chain Drug Review
chief information officer, chief technology officer, CIO, John Hammergren, Kathy McElligott, McKesson, Randy Spratt
2015, Issue 07-06-2015, Issues, News
SAN FRANCISCO — Kathy McElligott has been appointed executive vice president and chief information officer (CIO) and chief technology officer (CTO) at McKesson Corp. She comes to McKesson from Emerson, where she served as CIO since 2010 and managed Emerson’s information technology strategy and information security for its global operations. McElligott succeeds Randy Spratt, who
July 6, 2015 by Jeffrey Woldt and Chain Drug Review
CVS Health, CVS/pharmacy, CVS/pharmacy y más, Jeffrey Woldt, Larry Merlo, Omnicare, Target Corp.
2015, Issue 07-06-2015, Issues, Opinion

It was a very productive spring for CVS Health. Already performing at a level that made it the envy of most other retailers and health care providers, the company took a series of steps in May and June that will increase its chances of success in several burgeoning sectors of the marketplace. The biggest news
July 6, 2015 by David Pinto and Chain Drug Review
David Pinto, Target-CVS
2015, Issue 07-06-2015, Issues, Opinion

CVS’ announced intention to buy Target’s pharmacy and immediate care clinic businesses has stunned a mass retailing community already subject to numerous shocks this year. To recap briefly, mass retailing has seen new alliances, new executive appointments and promotions, bold new ventures, and a newly revised view of the mass retailing community based on a